(Q36055013)

11 August 2017

The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing (English)

1 reference

11 August 2017

0 references

1 reference

7

G I Town

1 reference

11 August 2017

1

E J Begg

1 reference

11 August 2017

R A Robson

2

1 reference

11 August 2017

D A Saunders

3

1 reference

11 August 2017

G G Graham

4

1 reference

11 August 2017

R C Buttimore

5

1 reference

11 August 2017

A M Neill

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

49

1 reference

11 August 2017

1

1 reference

11 August 2017

32-38

1 reference

Penetration of fleroxacin into body tissues and fluids.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014894

Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014894

In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014894

Clinical pharmacokinetics of ciprofloxacin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014894

Fleroxacin clinical pharmacokinetics

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014894

Anomalous parameter estimates in the one-compartment model with first-order absorption.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014894

Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxacin.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014894

Single and multiple dose pharmacokinetics of fleroxacin.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014894

Simultaneous pharmacokinetic and pharmacodynamic modeling

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014894

Drug kinetics in low-flux (small) anatomic compartments

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014894

In-vitro activity of fleroxacin

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014894

Respiratory tract penetration of ciprofloxacin

23 September 2018

1 reference

12 December 2020

Rapid HPLC assay of fluoroquinolones in clinical specimens

1 reference

12 December 2020

Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration

1 reference

12 December 2020

Penetration of ciprofloxacin into human lung tissue following intravenous injection

1 reference

12 December 2020

High-performance liquid chromatography of ciprofloxacin and its metabolites in serum, urine and sputum

1 reference

12 December 2020

10.1046/J.1365-2125.2000.00105.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

10606835

1 reference